Improving cancer treatment through efficient clinical trials
Core B: Clinical Trials Core
This study is working to make it easier and faster to test new cancer treatments at the University of Michigan, so that patients can benefit from the latest discoveries more quickly and effectively.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10917038 on NIH RePORTER |
What this research studies
This research focuses on enhancing the process of conducting clinical trials for cancer treatments at the University of Michigan Rogel Cancer Center. It aims to streamline the transition of basic science discoveries into clinical applications, ensuring that new therapies can be tested quickly and effectively. The project will establish a robust infrastructure to support all phases of clinical trials, including participant recruitment, informed consent, and adherence to Good Clinical Practice standards. By coordinating efforts among various departments, the research seeks to improve the overall efficiency and success rates of cancer trials.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with locally advanced cancers who are seeking innovative treatment options.
Not a fit: Patients with early-stage cancers or those not eligible for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective cancer treatments for patients.
How similar studies have performed: Previous research has demonstrated that streamlined clinical trial processes can significantly enhance patient outcomes and treatment efficacy.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Schuetze, Scott Michael — University of Michigan at Ann Arbor
- Study coordinator: Schuetze, Scott Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.